Profile data is unavailable for this security.
About the company
China Animal Husbandry Industry Co Ltd is a China-based company mainly engaged in the research and development, production, sales and technical services of animal health care products and animal nutrition products. The Company operates four segments. The Animal Disease Prevention and Control segment mainly provides veterinary biological products, including vaccines for poultry, livestock and pets. The Animal Disease Treatment segment mainly provides veterinary chemical drugs, including veterinary drug preparations and raw materials for veterinary drugs. The Animal Nutrition segment mainly provides feed and feed additive products, including compound vitamins and compound premixes. The Others segments are engaged in trade business, including the trade of feed raw materials and feed additives such as corn and corn by-products, soybean meal, fish meal and lysine. The Company principally conducts its business in domestic market.
- Revenue in CNY (TTM)6.28bn
- Net income in CNY214.44m
- Incorporated1998
- Employees4.30k
- LocationChina Animal Husbandry Industry Co LtdNo. 16-17 BuildingSection 8, Headquarters BaseBEIJING 100070ChinaCHN
- Phone+86 1 063702195
- Fax+86 1 063701950
- Websitehttps://www.cahic.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wuhan Keqian Biology Co Ltd | 1.01bn | 459.54m | 7.64bn | 924.00 | 16.74 | 1.83 | -- | 7.54 | 0.9796 | 0.9796 | 2.16 | 8.95 | 0.2209 | 2.86 | 3.23 | 1,097,706.00 | 9.97 | 11.71 | 11.17 | 13.56 | 65.26 | 73.57 | 45.16 | 44.51 | 5.02 | -- | 0.0017 | 32.23 | -11.48 | 13.17 | -3.43 | 9.52 | -4.93 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.78bn | 214.11m | 7.72bn | 3.63k | 35.95 | 1.84 | -- | 2.04 | 0.2112 | 0.2112 | 3.72 | 4.12 | 0.633 | 3.37 | 7.63 | 1,040,448.00 | 4.45 | 0.7994 | 6.29 | 5.29 | 51.41 | 23.96 | 7.02 | 3.71 | 3.96 | -- | 0.0393 | 43.21 | -13.02 | -17.29 | -19.73 | -6.70 | 21.16 | 0.00 |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 1.60bn | -332.62m | 7.89bn | 2.35k | -- | 1.08 | -- | 4.95 | -0.3545 | -0.3545 | 1.70 | 7.75 | 0.1303 | 0.6358 | 0.4977 | 679,399.90 | -2.74 | 3.29 | -3.80 | 4.46 | 44.16 | 37.24 | -21.03 | 10.59 | 1.33 | -1.45 | 0.3114 | 24.43 | -13.90 | -3.87 | -7.30 | 1.41 | 1.13 | -7.12 |
| Cisen Pharmaceutical Co Ltd | 3.56bn | 492.80m | 7.96bn | 3.30k | 16.21 | 1.29 | -- | 2.23 | 1.08 | 1.08 | 7.84 | 13.59 | 0.472 | 2.10 | 5.34 | 1,079,074.00 | 6.58 | 6.51 | 8.12 | 8.07 | 53.70 | 55.92 | 13.94 | 10.84 | 3.48 | -- | 0.0069 | 37.16 | -10.77 | -0.6464 | -2.38 | -0.2215 | -0.3051 | 10.42 |
| China Animal Husbandry Industry Co., Ltd | 6.28bn | 214.44m | 7.98bn | 4.30k | 37.19 | 1.39 | -- | 1.27 | 0.21 | 0.21 | 6.15 | 5.60 | 0.6863 | 5.30 | 4.19 | 1,461,064.00 | 2.32 | 5.25 | 3.37 | 7.48 | 15.59 | 22.15 | 3.38 | 7.31 | 1.62 | -- | 0.1625 | 31.16 | 11.30 | 7.79 | -82.41 | -22.24 | -0.0699 | -21.83 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 751.12m | 184.84m | 8.20bn | 1.22k | 44.04 | 3.49 | -- | 10.91 | 0.2241 | 0.2241 | 0.8963 | 2.83 | 0.2472 | 0.9248 | 3.00 | 616,180.10 | 6.08 | 8.91 | 7.77 | 12.10 | 51.51 | 53.44 | 24.61 | 27.68 | 2.17 | -- | 0.1383 | 27.35 | -2.63 | 20.90 | -18.55 | 29.68 | 17.53 | 43.79 |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 2.29bn | -363.56m | 8.22bn | 2.97k | -- | 1.42 | -- | 3.58 | -0.1112 | -0.1112 | 0.7189 | 1.82 | 0.204 | 2.09 | 3.30 | 771,487.60 | -4.90 | -0.1745 | -7.79 | -0.2739 | 34.13 | 64.36 | -24.05 | -0.6631 | 2.01 | -5.26 | 0.2563 | 69.54 | -26.67 | -9.85 | -547.14 | -- | 4.41 | -- |
| Changchun BCHT Biotechnology Co | 677.51m | -170.53m | 8.31bn | 1.27k | -- | 2.10 | -- | 12.27 | -0.4124 | -0.4124 | 1.64 | 9.57 | 0.1288 | 0.7183 | 0.4756 | 531,801.10 | -3.24 | 8.14 | -4.12 | 10.19 | 77.22 | 85.58 | -25.17 | 23.29 | 1.20 | -8.89 | 0.0696 | 14.91 | -32.64 | 4.73 | -53.67 | 0.9824 | 33.40 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 7.27m | 0.71% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 4.75m | 0.47% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 3.84m | 0.38% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 3.30m | 0.32% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 2.55m | 0.25% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.54m | 0.25% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.40m | 0.24% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 1.85m | 0.18% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.72m | 0.17% |
| Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2025 | 1.51m | 0.15% |
